February 2017 – Page 3 – Policy & Medicine

FDA Finalizes Guidance on Assigning Non-Proprietary Names to Biologics and Biosimilars

CMS Missing Critical QPP Infrastructure

2017 Biosimilar Update

FDA Announces Safety Labeling Changes Program

Discussion on Open Payments by Philadelphia-Region Doctors

Department of Justice Increases FCA Civil Penalties, Again

Tom Price on MACRA and Value-Based Care

Walgreens to Pay $50M to Settle Anti-Kickback Suit

Zimmer Biomet Pays $30 Million to Resolve New FCPA Charges

Stark Law Regulatory Changes for 2017